Bruker Corp Files 8-K on Financials
Ticker: BRKRP · Form: 8-K · Filed: Feb 13, 2025 · CIK: 1109354
| Field | Detail |
|---|---|
| Company | Bruker Corp (BRKRP) |
| Form Type | 8-K |
| Filed Date | Feb 13, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-condition, results-of-operations
Related Tickers: BRKR
TL;DR
Bruker Corp filed an 8-K on Feb 13, 2025, updating financials.
AI Summary
Bruker Corporation filed an 8-K on February 13, 2025, reporting on its results of operations and financial condition. The filing includes financial statements and exhibits, with the report period ending on February 13, 2025. Bruker Corporation, incorporated in Delaware, is headquartered at 40 Manning Road, Billerica, MA.
Why It Matters
This 8-K filing provides an update on Bruker Corporation's financial performance and condition, which is crucial information for investors to assess the company's health and future prospects.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of financial information and does not appear to contain any significant new risks or adverse events.
Key Players & Entities
- Bruker Corporation (company) — Registrant
- February 13, 2025 (date) — Date of Report
- 40 Manning Road, Billerica, MA (location) — Principal executive offices
FAQ
What specific financial information is being reported in this 8-K?
The 8-K filing indicates it pertains to 'Results of Operations and Financial Condition' and includes 'Financial Statements and Exhibits'.
When was this 8-K report filed?
The report was filed on February 13, 2025.
What is the principal business address of Bruker Corporation?
The principal executive offices are located at 40 Manning Road, Billerica, MA 01821.
Under which section of the Securities Exchange Act of 1934 is this report filed?
This report is filed pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934.
What is Bruker Corporation's fiscal year end?
Bruker Corporation's fiscal year ends on December 31.
Filing Stats: 562 words · 2 min read · ~2 pages · Grade level 11.3 · Accepted 2025-02-13 07:00:10
Key Financial Figures
- $0.01 — nge on Which Registered Common Stock, $0.01 par value per share BRKR The Nasdaq
Filing Documents
- brkr-20250213.htm (8-K) — 53KB
- brkr-ex99_1.htm (EX-99.1) — 1470KB
- img53376846_0.jpg (GRAPHIC) — 37KB
- 0000950170-25-019332.txt ( ) — 1741KB
- brkr-20250213.xsd (EX-101.SCH) — 29KB
- brkr-20250213_htm.xml (XML) — 4KB
02. Results of Operations and Financial Condition
Item 2.02. Results of Operations and Financial Condition. On February 13, 2025, Bruker Corporation issued a press release announcing financial results as of and for the three months and year ended December 31, 2024. A copy of the press release is attached hereto as Exhibit 99.1. The information furnished in this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and shall not be incorporated by reference into any filing of the company under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing. Cautionary Note Regarding Forward-Looking Statements Except for historical information contained in the press release attached hereto as Exhibit 99.1, the press release contains forward-looking statements that involve certain risks and uncertainties that could cause actual results to differ materially from those indicated by these statements. Please refer to the cautionary note contained in the press release under the heading "Forward-Looking Statements" for additional information regarding these forward-looking statements. Section 9 – Financial Statements and Exhibits
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d) Exhibits. Number Description 99.1 Press release dated February 13, 2025. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. BRUKER CORPORATION (Registrant) Date: February 13, 2025 By: /s/ GERALD N. HERMAN Gerald N. Herman Executive Vice President and Chief Financial Officer